Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease

Detalles Bibliográficos
Autores principales: Frey, Sarah, Chiang, Teresa Po-Yu, Connolly, Caoilfhionn M, Teles, Mayan, Alejo, Jennifer L, Boyarsky, Brian J, Christopher-Stine, Lisa, Werbel, William A, Massie, Allan B, Segev, Dorry L, Paik, Julie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765758/
https://www.ncbi.nlm.nih.gov/pubmed/35072108
http://dx.doi.org/10.1016/S2665-9913(21)00417-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765758/
https://www.ncbi.nlm.nih.gov/pubmed/35072108
http://dx.doi.org/10.1016/S2665-9913(21)00417-3

Ejemplares similares